Member Info for notrac

Promotion.

I also mentioned the key issue of greater efficacy when compared to placebo in my message on this board on Sept 12th 2019 but I am not crowing about it. This had been the problem for IMM in April 2018. IMM are now having to another Phase III trial.
The main cause of ED is old age, as Dr. Hellstrom pointed out in his conversation with Ken James shown on here about a month ago: it's not in the mind. FUM would be well advised to look at how STX got Ferracru accepted by the FDA. They first got in accepted in Europe and then in the USA.

Suspect that LO have been selling. Think they paid 7p in the last round.

So the placebo was another in-house product. Confused.

The shares were sold on Thursday. Lanstead are the go to funder for IMM. They will clearly participate in the next funding round whenever that takes place.

I have taken a look at the presentation made in August and the company stated that they had enough funds until Q3 2020. They were very keen that any deal included an upfront sum and they wanted to close a deal before year-end. They will certainly need to resolve the funding situation before the accounts get signed off (spring 2020) by the auditors.

Richard Griffiths. I wonder why he sold a part of his holding. Could it be to fund his share in a placing? I have seen it done before.

...will have to wait till tomorrow. Today the US markets are closed.

Now down to 3.6%

LO lightening a tad. That's why it was down yesterday.

The guy's name is Hellstrom, clearly of Swedish origin. Anyone remember the Swedish goalkeeper, Ronnie Hellström?

I was a holder in SOU in 2017 and was left bemused as to why the previous CFO, a lady called Mary, left amid all the clamour of golden tickets. CFO's leaving is never a good sign.

One part of the tweet say 2NB, the other says 140 million BOE. Whatever number is right, UJO holds about 16%.

Judging by last week's price action 530p is holding as support. There has also been a slight reduction in the shorts.

The price has gapped up to above 720p (resistance level for PHNX). Is everyone thinking that the UK is going to reach a deal? Sterling and the banks are strong.

Dealings in the placing shares will commence on Oct 29th.

If the nominal value is one tenth of a penny and the issue price is say 1p, that means nine-tenths will go to the share premium account. A capital raise is £24 million (share premium 21.6 million), results in another 2.4 bilion shares on top of the 4.1 billion shares already issued. Will need to consolidate.

Maybe he's looking to get into Reabold on the cheap.

British Bulsl are a bit late. Why wait to 2925? Whatever one may say about crossing moving averages, charts do point out support and resistance levels. Currently 2800 is support and 3100 is resistance.
I expect this message will be removed.

A quick look at the charts showed that it hit 138p in mid 2018. A lot lower at the end of 2015.